Haemophilus influenzae infection: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 27: | Line 27: | ||
== Treatment == | == Treatment == | ||
[[Haemophilus influenzae serotype B infection medical therapy|Medical Therapy]] | [[Haemophilus influenzae serotype B infection primary prevention|Primary Prevention]] | [[Haemophilus influenzae serotype B infection cost- | [[Haemophilus influenzae serotype B infection medical therapy|Medical Therapy]] | [[Haemophilus influenzae serotype B infection primary prevention|Primary Prevention]] | [[Haemophilus influenzae serotype B infection cost-effectivenss of therapy|Cost-Effectiveness of therapy]] | [[Haemophilus influenzae serotype B infection future or investigational therapies|Future or Investigational Therapies]] | ||
==Case Studies== | ==Case Studies== | ||
Revision as of 21:09, 5 December 2012
|
Haemophilus influenzae infection Main page |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: Hib disease
Overview
Pathophysiology
Causes
Differentiating Haemophilus influenzae serotype B infection from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Chest X Ray | Other Diagnostic Studies
Treatment
Medical Therapy | Primary Prevention | Cost-Effectiveness of therapy | Future or Investigational Therapies